GN Store Nord AS GN

Morningstar Rating
DKK 96.14 −1.70 (1.74%)
View Full Chart

Company Report

Price vs Fair Value

GN is trading at a LOCK|pN!^n? premium.
Price
DKK 96.14
Fair Value
LOCK|T@
Uncertainty
LOCK|qB
1-Star Price
LOCK|k.p
5-Star Price
LOCK|.g$
Economic Moat
LOCK|YQ
Capital Allocation
LOCK|rnX^d$

Bulls Say, Bears Say

Bulls

GN has strong relationships with large retailers, allowing it to generate high volume and benefit from scale. It is likely that these large retailers will continue to gain market share in the long term.

Bears

GN’s OTC expansion could destroy value if adoption is constrained by skepticism about self-fitting, while lower-priced Jabra devices could cannibalize midtier ReSound products.

Trading Information

Previous Close Price
DKK 97.84
Day Range
DKK 95.9898.42
52-Week Range
DKK 85.12123.75
Bid/Ask
DKK 96.10 / DKK 96.20
Shares Outstanding
145.61M
Market Cap
DKK 14.00B
Volume/Avg
321,858 / 563,844

Key Statistics

Price/Earnings (Normalized)
138.86
Price/Sales
1.09
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
Total Yield

Company Profile

GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
7,736

Competitors

Valuation

Metric
GN
SOON
DEMANT
Price/Earnings (Normalized)
138.8623.4323.86
Price/Book Value
1.365.345.47
Price/Sales
1.093.882.50
Price/Cash Flow
6.1118.1314.40
Price/Earnings
GN
SOON
DEMANT

Financial Strength

Metric
GN
SOON
DEMANT
Quick Ratio
0.381.170.54
Current Ratio
1.931.750.82
Interest Coverage
0.1823.146.70
Quick Ratio
GN
SOON
DEMANT

Profitability

Metric
GN
SOON
DEMANT
Return on Assets (Normalized)
−0.53%11.07%6.76%
Return on Equity (Normalized)
−1.48%24.50%24.80%
Return on Invested Capital (Normalized)
0.50%16.97%9.75%
Return on Assets
GN
SOON
DEMANT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|>?@MS$ZLOCK|L?WfK$187B
Medtronic PLC
MDT
LOCK|Wk^S#TWLOCK|!Y^<R$120B
Stryker Corp
SYK
LOCK|nYT$&V?LOCK|%v$116B
Boston Scientific Corp
BSX
LOCK|kn<^l^LOCK|Ww!n$69B
Edwards Lifesciences Corp
EW
LOCK|GxhP?kHGLOCK|VPJd<$52B
DexCom Inc
DXCM
LOCK|$Qk%pN^LOCK|$$HF#$33B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|^qxKgzQLOCK|^N$31B
Koninklijke Philips NV ADR
PHG
LOCK|@KLOCK|@>$25B
Steris PLC
STE
LOCK|qCB@RQ@LOCK|J&^y$22B
Zimmer Biomet Holdings Inc
ZBH
LOCK|#r!CWKrfLOCK|^k$19B

Sponsor Center